A retrospective, multicenter comparison study of ("low dose") and ("standard dose") intravitreal afliberceptin the treatment of retinopathy of prematurity
Latest Information Update: 07 Sep 2021
At a glance
- Drugs Aflibercept (Primary)
- Indications Retinopathy of prematurity
- Focus Therapeutic Use
- 07 Sep 2021 New trial record